Bristol-Myers Squibb Company (BMY) FY 2025 Conference May 28, 2025 03:30 PM ET Speaker0 Fantastic. Hi everyone. It's great to have you here for this fireside, the first of our pharmaceutical firesides during the FTC. My name is Courtney Breen. I am the U. S. Biopharma Analyst here at Bernstein, and I am thrilled to have Chris Borner here with me today from Bristol. I will hand over to him to give you a little bit of his background, but also share some opening remarks on what's going on at Bristol in the ind ...